Trial Profile
A study of evaluating Perindopril treatment adherence based on Therapeutic drug monitoring and pharmacokinetic simulations.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Choroidal neovascularisation
- Focus Adverse reactions; Therapeutic Use
- Acronyms PIXEL
- Sponsors Novartis Pharma
- 11 Dec 2017 New trial record.